According to our results, abolishment of REMS decreased nesfatin mRNA and protein expression in the DLH, a prominent site of nesfatin expression implicated in vigilance, feeding and depression [13], [18], [31], [32], while the subsequent REMS rebound restored these levels. The gene discussed is NUCB2; the disease is depressive symptom measurement.